# Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans

> **NCT03179163** · PHASE1,PHASE2 · TERMINATED · sponsor: **Penn State University** · enrollment: 10 (actual)

## Conditions studied

- Hypertension,Essential

## Interventions

- **DRUG:** Captopril Pill
- **DRUG:** Enalapril Pill
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT03179163
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-20
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** COVID shut down human subjects research and then the grant funding expired
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03179163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03179163, "Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03179163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*